As gains in malaria control continue to be made, more malaria-endemic countries are pursuing elimination. To achieve elimination, more evidence is needed to determine the combination of interventions that has the highest impact and is the most cost-effective given the prevalence.
On Thursday, November 2nd, the HFG-led Malaria Economic Research Community of Practice hosted an an hour-long webinar to discuss how cost-effectiveness is viewed in the context of elimination and how it differs from that of a control setting.
Building on the approach used in a recent cost-effectiveness study conducted in Senegal using routine program data, panelists discussed the application of cost-effectiveness analyses in elimination settings. Panelists further discussed the programmatic and policy-related implications of the results of cost-effectiveness analyses and the additional economic evidence needed to guide country-level decision-making on elimination efforts.
- Sophie Faye, Costing and Economic Specialist, Health Finance and Governance Project, Abt Associates
- Alioune Badara Gueye, Case Management, Training, and Research Officer, Senegal National Malaria Control Program
- Justice Nonvignon, Senior Lecturer and Health Economist, University of Ghana School of Public Health
- Rima Shretta, Associate Director of Economics & Financing, UCSF Global Health Group’s Malaria Elimination Initiative (MEI)
- Duncan Earle, Director for Country Programs, Malaria Control and Elimination Partnership in Africa (MACEPA)
- Elaine Baruwa, Senior Health Economist, Health Finance and Governance Project, Abt Associates
- Kelley Ambrose, Senior Analyst and Technical Program Officer, Health Finance and Governance Project, Abt Associates